[ad_1]
FSD Pharma (CSE: HUGE-OTCQB: FSDDF) Dr. Raza Bokhari, Executive Co-President and Chief Executive Officer, spoke with Steve Darling of Proactive Investors Vancouver to discuss the fact that the FSD has taken a significant step forward. obtaining a cannabis license from Health Canada.
Dr. Bokhari also spoke to Proactive about the recent acquisition of Prismic Pharmaceuticals. In the United States, this pharmaceutical company specializing in research and development is developing new addictive prescription drugs with unique safety profiles to address the opioid crisis from formulations using "Surrounding" effect of micro-palmitoylethanolamide on certain drugs having an impact on the endocannabinoid system.
Source link
